Please Wait.....
Report
Single-cell Omics: Emerging Technologies and Markets
Market Research Report I 2025-04-04 I 129 Pages I BCC Research
Description
Report Scope:
The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.
The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.
Report Includes:
- 43 data tables and 59 additional tables
- An overview of the global markets and emerging technologies for single-cell genomics and proteomics
- Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region
- Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification
- Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics
- Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years
- Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology
- A discussion of the industry's ESG challenges and practices
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
- Insight into industry structure, competitive landscape, clinical trials and ongoing research activity
- Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA
Executive Summary
Summary:
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
The demand for single-cell genomics and proteomics is rapidly increasing across global research and healthcare markets, driven by advances in single-cell analysis technologies and their ability to provide unprecedented insights into cellular heterogeneity. With the rising focus on personalized medicine, oncology and immune profiling, single-cell technologies are becoming indispensable tools for identifying biomarkers, understanding disease mechanisms and developing targeted therapies.
The growing prevalence of chronic and complex diseases, such as cancer, neurodegenerative disorders and autoimmune diseases, has highlighted the importance of single-cell approaches in precision medicine. These technologies enable researchers to study individual cells at genomic and proteomic levels, uncovering critical information that bulk analysis often misses. The significant investments in single-cell research, coupled with ongoing technological innovations in sequencing, mass spectrometry and data analysis platforms, are fueling the adoption of single-cell genomics and proteomics. Increasing collaborations between academic institutions, biotech companies, and healthcare providers are further accelerating the development and commercialization of single-cell technologies. Comprehensive market sizing and forecasting will enable stakeholders to identify high-growth segments and regions, understand competitive dynamics and make informed decisions for strategic planning during the forecast period.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Technology Background
Types of Omics
Technological Infrastructure and Data Integration
Macroeconomic Factors Analysis
Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
Economic Uncertainty and Research Funding Cuts
Increased Operational Costs
Shift in Geopolitical Collaborations
Sanctions on Russia and Technology Exports
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential of New Entrants
Competition in the Industry
Threat of Substitutes
Chapter 3 Regulatory Landscape
Regulatory Overview
Market Regulations by Country/Region
Federal Regulation
CMS Regulation
FDA Regulation
FTC Regulation
Canada
European Union
United Kingdom (U.K.)
China
Japan
Australia
International Standards and Guidelines
Chapter 4 Market Dynamics
Market Dynamics
Market Drivers
Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
Market Restraints
High Costs Associated with Single-cell Proteomics
Technical Challenges
Market Opportunities
Technological Advances and Automation in Single-cell Studies
Collaboration and Partnerships
Chapter 5 Emerging Technologies and Developments
Artificial Intelligence in Single-cell Genomics and Proteomics
Companies in the AI Single-cell Genomics and Proteomics Market
Advances in Single-cell Omics and Multi-omics
Chapter 6 Market Segmentation Analysis
Market Overview
Segmentation Breakdown
Global Single-cell Genomics and Proteomics Market by Analysis Type
Single-cell Genomics
Single-cell Proteomics
Single-cell Transcriptomics
Single-cell Epigenomics
Global Single-cell Genomics and Proteomics Market by Application
Oncology
Stem Cell Biology
Immunology
Other Applications
Global Single-cell Genomics and Proteomics Market by End User
Academic and Research Organizations
Biopharmaceutical and Biotechnology Companies
Clinical Laboratories
Applied Markets
Geographic Breakdown
Global Single-cell Genomics and Proteomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Overview
Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Patent Analysis
Takeaways
Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective
Introduction to ESG
ESG Performance in the Market
ESG Practices in the Genomics and Proteomics Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 9 Appendix
Methodology
Abbreviations
Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
MERCK KGAA
PROMEGA CORP.
QIAGEN
SARTORIUS AG
STANDARD BIOTOOLS
TECAN TRADING AG
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 1 : Molecular Biology Technologies for Multi-omics Approaches
Table 2 : Single-cell and Spatial Omics Technologies, 2018-2023
Table 3 : Companies in the AI Single-cell Genomics and Proteomics Market
Table 4 : Global Single-cell Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 5 : Global Single-cell Genomics Market, by Region, Through 2029
Table 6 : Global Single-cell Proteomics Market, by Region, Through 2029
Table 7 : Global Single-cell Transcriptomics Market, by Region, Through 2029
Table 8 : Global Single-cell Epigenomics Market, by Region, Through 2029
Table 9 : Global Single-cell Genomics and Proteomics Market, by Application, Through 2029
Table 10 : Global Single-cell Genomics and Proteomics Market for Oncology, by Region, Through 2029
Table 11 : Global Single-cell Genomics and Proteomics Market for Stem Cell Biology, by Region, Through 2029
Table 12 : Global Single-cell Genomics and Proteomics Market for Immunology, by Region, Through 2029
Table 13 : Global Single-cell Genomics and Proteomics Market for Other Applications, by Region, Through 2029
Table 14 : Global Single-cell Genomics and Proteomics Market, by End User, Through 2029
Table 15 : Global Single-cell Genomics and Proteomics Market for Academic and Research Organizations, by Region, Through 2029
Table 16 : Global Single-cell Genomics and Proteomics Market for Biopharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 17 : Global Single-cell Genomics and Proteomics Market for Clinical Laboratories, by Region, Through 2029
Table 18 : Global Single-cell Genomics and Proteomics Market for Applied Markets, by Region, Through 2029
Table 19 : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
Table 20 : North American Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 21 : North American Genomics and Proteomics Market, by Application, Through 2029
Table 22 : North American Genomics and Proteomics Market, by End User, Through 2029
Table 23 : European Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 24 : European Genomics and Proteomics Market, by Application, Through 2029
Table 25 : European Genomics and Proteomics Market, by End User, Through 2029
Table 26 : Asia-Pacific Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 27 : Asia-Pacific Genomics and Proteomics Market, by Application, Through 2029
Table 28 : Asia-Pacific Genomics and Proteomics Market, by End User, Through 2029
Table 29 : RoW Genomics and Proteomics Market, by Analysis Type, Through 2029
Table 30 : RoW Genomics and Proteomics Market, by Application, Through 2029
Table 31 : RoW Genomics and Proteomics Market, by End User, Through 2029
Table 32 : Top Players in the Single-cell Genomics and Proteomics Market, 2023
Table 33 : Collaborations and Partnerships: Single-cell Genomics and Proteomics Market, 2021-2024
Table 34 : New Product Launch: Single-cell Genomics and Proteomics Market, 2021-2024
Table 35 : Expansions and Investments: Single-cell Genomics and Proteomics Market, 2021-2024
Table 36 : Mergers and Acquisitions: Single-cell Genomics and Proteomics Market, 2020-2024
Table 37 : Single-cell Genomics and Proteomics Market: Patent Analysis, 2018-2024
Table 38 : Key Focus Areas in ESG Metrics
Table 39 : Environmental Performance Initiatives in the Genomics and Proteomics Market
Table 40 : Social Performance Initiatives in the Genomics and Proteomics Market
Table 41 : Governance Performance Initiatives in the Genomics and Proteomics Market
Table 42 : ESG Rankings for Genomics and Proteomics Companies, 2024*
Table 43 : Abbreviations Used in this Report
Table 44 : 10x Genomics: Company Snapshot
Table 45 : 10x Genomics: Financial Performance, FY 2022 and 2023
Table 46 : 10x Genomics: Product Portfolio
Table 47 : 10x Genomics: News/Key Developments, 2024
Table 48 : Agilent Technologies Inc.: Company Snapshot
Table 49 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Agilent Technologies Inc.: Product Portfolio
Table 51 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 52 : BD: Company Snapshot
Table 53 : BD: Financial Performance, FY 2023 and 2024
Table 54 : BD: Product Portfolio
Table 55 : BD: News/Key Developments, 2023-2024
Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 60 : Bio-Techne: Company Snapshot
Table 61 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 62 : Bio-Techne: Product Portfolio
Table 63 : Bio-Techne: News/Key Developments, 2022
Table 64 : Bruker: Company Snapshot
Table 65 : Bruker: Financial Performance, FY 2022 and 2023
Table 66 : Bruker: Product Portfolio
Table 67 : Bruker: News/Key Developments, 2024
Table 68 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 69 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 70 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 71 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021-2022
Table 72 : Illumina Inc.: Company Snapshot
Table 73 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 74 : Illumina Inc.: Product Portfolio
Table 75 : Illumina Inc.: News/Key Developments, 2022-2023
Table 76 : Merck KGaA: Company Snapshot
Table 77 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 78 : Merck KGaA: Product Portfolio
Table 79 : Promega Corp.: Company Snapshot
Table 80 : Promega Corp.: Product Portfolio
Table 81 : Promega Corp.: News/Key Developments, 2022-2023
Table 82 : Qiagen: Company Snapshot
Table 83 : Qiagen: Financial Performance, FY 2022 and 2023
Table 84 : Qiagen: Product Portfolio
Table 85 : Qiagen: News/Key Developments, 2022-2024
Table 86 : Sartorius AG: Company Snapshot
Table 87 : Sartorius AG: Financial Performance, FY 2022 and 2023
Table 88 : Sartorius AG: Product Portfolio
Table 89 : Sartorius AG: News/Key Developments, 2024
Table 90 : Standard BioTools: Company Snapshot
Table 91 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 92 : Standard BioTools: Product Portfolio
Table 93 : Standard BioTools: News/Key Developments, 2022-2024
Table 94 : Tecan Trading AG: Company Snapshot
Table 95 : Tecan Trading AG: Financial Performance, FY 2022 and 2023
Table 96 : Tecan Trading AG: Product Portfolio
Table 97 : Tecan Trading AG: News/Key Developments, 2024
Table 98 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 99 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 100 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 101 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024
List of Figures
Summary Figure : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 1 : Types of Omics
Figure 2 : Porter's Five Forces Analysis for the Single-cell Genomics and Proteomics Market
Figure 3 : Market Dynamics of Single-cell Genomics and Proteomics
Figure 4 : Global Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 5 : Global Single-cell Genomics Market Share, by Region, 2023
Figure 6 : Global Single-cell Proteomics Market Share, by Region, 2023
Figure 7 : Global Single-cell Transcriptomics Market Share, by Region, 2023
Figure 8 : Global Single-cell Epigenomics Market Share, by Region, 2023
Figure 9 : Global Single-cell Genomics and Proteomics Market Share, by Application, 2023
Figure 10 : Global Single-cell Genomics and Proteomics Market Share, by End User, 2023
Figure 11 : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
Figure 12 : North American Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 13 : European Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 14 : Asia-Pacific Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 15 : RoW Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
Figure 16 : Snapshot of ESG Pillars
Figure 17 : Advantages of ESG for Companies
Figure 18 : Share of Biotech Companies Providing ESG Disclosure, 2022
Figure 19 : Share of ESG Disclosure Location for the Biotech Companies, 2022
Figure 20 : 10x Genomics: Revenue Share, by Business Unit, FY 2023
Figure 21 : 10x Genomics: Revenue Share, by Country/Region, FY 2023
Figure 22 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 23 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 24 : BD: Revenue Share, by Business Unit, FY 2024
Figure 25 : BD: Revenue Share, by Country/Region, FY 2024
Figure 26 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 27 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 30 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 31 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 32 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 33 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 38 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 39 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 42 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 43 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 44 : Tecan Trading AG: Revenue Share, by Business Unit, FY 2023
Figure 45 : Tecan Trading AG: Revenue Share, by Country/Region, FY 2023
Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 47 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security